«
»

Top

What is biologic therapy? Asthma special

Jan 20, 2020

In some cases, asthmatic patients may be prescribed a biologic therapy: what patients may benefit? How does it work? What are the potential side effects? Read our guide to learn more about these innovative treatments.

What is biologic therapy? Asthma special

Asthma and biologic therapies

Asthma is a chronic respiratory pathology, that can grow progressively more severe. There are two types:

- Atopic asthma, provoked by allergies, it is the most common form and generally begins in childhood or adolescence.

- Intrinsic asthma, non-allergic, it generally manifests later in life.

Beginning in the last few years, biologic therapies have been developed for the treatment of asthma; this is especially the case for atopic asthma. These new treatments target the molecules responsible for an inflammatory reaction, which along with bronchial spasms (narrowing of the bronchial tubes) is one of the main features of an asthma attack. Biologic therapies are not necessary for every asthma patient and are not prescribed until the patient has been thoroughly evaluated.

How do they work?

The biologic therapies used to treat asthma are composed of monoclonal antibodies which target the molecules responsible for an allergic reaction such as IgE (Immunoglobulin E), cytokines or sometimes chemokines. By blocking these molecules, they prevent the activation of pro-inflammation cells and the ensuing allergic and inflammatory reaction observed during an asthma attack.

What is the role of biologic therapies in asthma treatment?

In the case of respiratory pathologies such as asthma, biologic therapies play a rather limited role, in comparison to other domains like hematology or rheumatology. They're only recommended after three or four other treatments have failed to be effective and for patients suffering from severe allergic asthma, that is after a patient has thoroughly tested bronchodilator inhalers (Beta-adrenergic agonists et anticholinergic agents) and corticotherapy inhalers or tablets.

Several other conditions must be present to make a patient eligible for biologic therapy, including:

- Asthma that is poorly controlled despite the patient using high-dosage corticotherapy inhalers (above or equal to 1500 µg a day) or taking  corticotherapy orally;

- Symptoms growing consistently worse ;

- The presence of a bronchial obstruction less than or to equal to 60% of theoretical FVC;

- The presence of a total IgE rate of between 30 and 700 UI/mL

Biologic therapies may only be subscribed to adults and children over the age of 12.

What biologic therapies are available for asthma treatment?

There are variety of biologic therapies with each one targeting a different molecule:

- OMALIZUMAB (Xolair) an anti-IgE antibody

- MEPOLIZUMAB (Nucala) an anti-IL-5 (interleukin 5) antibody

- BENRALIZUMAB an anti-IL-5Rα antibody

- Anti-IL-3 antibodies

- DUPILUMAB an anti-IL-4R antibody

- ENBREL an anti-TNFα (a pro-inflammatory cytokine)

OMALIZUMAB and MEPOLIZUMAB are for the moment the only biologic therapies approved for asthma treatment, the others are still in the clinical trial stage.

How is Omalizumab taken?

The posology is determined by the patient's IgE serum levels and weight and varies by individual. It is administered under the skin by injection every 4 months. If the prescribed dose is greater than 300 mg (2 ampoules), it's broken up into 2 injections 15 days apart.

Is it effective?

Omalizumab has been shown to very effective in preventing an immediate response and a delayed bronchial response after exposure to an antigen (the triggering agent). It makes a better symptomological score possible as well as improved patient quality of life and a 50% reduction of the most severe exacerbations. It is indisputably a huge leap forward in the treatment of severe cortico-dependant allergic asthma.

What are its side effects?

Side effects are limited to soreness around the injection site and some urticarial reactions. The solutions may prove difficult to administer as the antibody is not easily dissolved and must be put through a magnetic stirrer for between 20 and 30 minutes.

If the patient shows no improvement after 4 months on a biologic therapy, the treatment is halted. Prolonging the treatment for more than 12 months or longer if beneficial effects are shown needs further study to prove that it's safe.

Warning, this article is meant as a general overview and in not meant to replace advice from a medical professional. It does not address all the potential variations that may occur from patient to patient. Every patient is different and should consult with their physician before modifying their medical treatment!


Article written by Camille Dauvergne, 4th year pharmacy student, reviewed by Louise Bollecker, Carenity Content Manager.

avatar Camille Dauvergne

Author: Camille Dauvergne, Junior Community Manager France

Camille Dauvergne is currently a Junior Community Manager at Carenity. She assists the France Community Manager in animating the platform, easing member navigation of the site and encouraging them to interact. Camille also participated in writing scientific articles published on the Health Magazine, as well as updating illness and medication fact sheets.

>> Learn more

Comments

You will also like

Cancer diagnosis: Carenity members tell their story

Acute lymphoid leukemia
Acute myeloid leukemia
Adamantinoma
Anal cancer
Astrocytoma
Basal cell carcinoma
Bladder cancer
Bone cancer
Brain tumor
Breast cancer
Cancer of the Pleura
Cancer of the vulva
Cervical cancer
Chordoma
Choriocarcinoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Colorectal cancer
Dermatofibrosarcoma protuberans
Endometrial cancer
Enteropancreatic endocrine tumor
Esophageal cancer
Ewing sarcoma
Extraskeletal myxoid chondrosarcoma
Gallbladder cancer
Gastric cancer
Gastrointestinal stromal tumor
Glial tumor
Glioblastoma
Hodgkin lymphoma
Kaposi sarcoma
Larynx cancer
Liver cancer
Lung cancer
Malignant tumor of the fallopian tube
Merkel tumor
Mesothelioma
Mouth cancer
Multiple endocrine neoplasia
Multiple myeloma
Myelodysplastic syndromes
Myelofibrosis
Nasopharyngeal cancer
Nephroblastoma
Neuroblastoma
Neuroendocrine tumor
Non-Hodgkin lymphoma
Ovarian cancer
Palate cancer
Pancreatic cancer
Parotid cancer
Pheochromocytoma
Primary peritoneal tumor
Prostate cancer
Renal cancer
Retinoblastoma
Rhabdoid tumor
Sézary syndrome
Skin cancer
Squamous cell carcinoma of head and neck
Testicular cancer
Throat cancer
Thymus cancer
Thyroid Cancer
Tongue cancer
Tonsil cancer
Vaginal Cancer
Waldenström macroglobulinemia

Cancer diagnosis: Carenity members tell their story

Read the article
Crohn's Disease diagnosis: Carenity members tell their story

Crohn's disease

Crohn's Disease diagnosis: Carenity members tell their story

Read the article
Our guide to getting the most out of doctor's appointments

Our guide to getting the most out of doctor's appointments

Read the article
Sleeping disturbances: when and how to treat them?

Sleeping disturbances: when and how to treat them?

Read the article